Secondary and tertiary prevention of type 2 diabetes: a study protocol for a randomized, controlled trial in community pharmacies in bavaria, germany

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: PRAX, Katja (Friedrich-Alexander University Erlangen-Nuremberg, Molecular & Clinical Pharmacy, Erlangen, Germany)
  • Co-author(s): Katja Prax: Molecular & Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
    Helmut Schlager: Scientific Institute for Prevention in Health Care (WIPIG), Munich, Germany
    Kristina Friedland: Molecular & Clinical Pharmacy, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
  • Abstract:

    Methods

    The study is a randomized, controlled trial in 26 community pharmacies in Bavaria. Participants will be patients with type 2 diabetes and at least one oral antidiabetic drug. The duration is one year. Three assessments take place at baseline, after 6 and 12 months. Laboratory data as HbA1c, fasting plasma glucose and blood pressure are

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login